For example, genome editing of the APP gene’s 3’-UTR in a humanized knock-in mouse model led to reduced Aβ pathology, highlighting the efficacy of CRISPR/Cas9 in mitigating Alzheimer’s Disease through protective mutations (Nagata et al., 2018). Here, APP is linked to Alzheimer disease.